Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.

Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.

Item
http://www.wikidata.org/entity/Q33785977
The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation.Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2',3'-dideoxy-3'-thiacytidineReversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectorsA mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection.Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance.Interplay between single resistance-associated mutations in the HIV-1 protease and viral infectivity, protease activity, and inhibitor sensitivityHIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease.Retrovirus entry by endocytosis and cathepsin proteases.Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors.Properties of wild-type, C-terminally truncated, and chimeric maedi-visna virus glycoprotein and putative pseudotyping of retroviral vector particles.
P2860

Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.

Item
http://www.wikidata.org/entity/Q33785977
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Cleavage of the murine leukemi ...... nhibition by matrix mutations.
@ast
Cleavage of the murine leukemi ...... nhibition by matrix mutations.
@en
type
label
Cleavage of the murine leukemi ...... nhibition by matrix mutations.
@ast
Cleavage of the murine leukemi ...... nhibition by matrix mutations.
@en
prefLabel
Cleavage of the murine leukemi ...... nhibition by matrix mutations.
@ast
Cleavage of the murine leukemi ...... nhibition by matrix mutations.
@en
P1433
P1476
P2093
P2860
P304
P31
P433
P478
P577
P698
P921
P932
P1433
P1476
Cleavage of the murine leukemi ...... inhibition by matrix mutations
@en
P2093
P2860
P304
P31
P433
P478
P577
P698
P921
P932